UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 1, 2017 (April 27, 2017)

PFIZER INC.
(Exact name of registrant as specified in its charter)

Delaware
1-3619
13-5315170
(State or other Jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)

235 East 42nd Street
New York, New York
(Address of principal executive offices)

 
10017
(Zip Code)

Registrant's telephone number, including area code:

(212) 733-2323

Not Applicable
(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[   ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[   ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[   ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[   ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company  [   ]

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.   [   ]

Item 5.07

Submission of Matters to a Vote of Security Holders

(a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 27, 2017.
 
(b) Shareholders voted on the matters set forth below.

1.  The nominees for election to the Company’s Board of Directors were elected to hold office until the Company’s next Annual Meeting of Shareholders, based upon the following votes:

Nominee
       Votes For
     Votes Against
         Abstentions
     Broker non-votes

Dennis A. Ausiello

4,152,501,049 75,514,314 13,839,358 922,977,815
Ronald E. Blaylock 4,164,933,510 62,636,919 14,294,069 922,977,815

W. Don Cornwell

4,027,032,793 200,454,995 14,382,843 922,977,815
Joseph J. Echevarria 4,175,460,147 52,326,845 14,082,675 922,977,815
Frances D. Fergusson 4,183,313,416 44,564,457 13,993,585 922,977,815

Helen H. Hobbs

4,203,418,078 25,415,701 13,037,680 922,977,815

James M. Kilts

3,428,377,699 788,781,156 24,712,604 922,977,815

Shantanu Narayen

4,187,489,160 40,233,206 14,148,394 922,977,815

Suzanne Nora Johnson

4,158,446,107 70,141,723 13,281,430 922,977,815

Ian C. Read

4,011,974,954 179,295,677 50,592,617 922,977,815

Stephen W. Sanger

4,106,265,694 97,150,063 38,455,076 922,977,815

James C. Smith

4,182,841,733 44,129,277 14,899,823 922,977,815

2.  The proposal to ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the 2017 fiscal year was approved based upon the following votes:

Votes for approval
5,018,058,421  
Votes against 127,091,711  
Abstentions 19,697,878  
Broker non-votes N/A  
     
3.  The proposal to approve, on an advisory basis, executive compensation was approved based upon the following votes:
     
Votes for approval
3,941,679,516  
Votes against 269,008,927
Abstentions 31,184,241  
Broker non-votes 922,977,815  
 
 
4. The proposal  on the frequency of future advisory votes on executive compensation received the following votes:  
     
For 3 years
526,554,428  
For 2 years 24,985,010  
For 1 Year 3,669,882,602  
Abstentions 20,344,405  
Broker non-votes 922,977,815  
 
5. The shareholder proposal regarding The Holy Land Principles was withdrawn by the proponent and not presented at the Annual Meeting.
     
     
6. The shareholder proposal regarding special shareowner meetings was not approved based upon the following votes:
     
Votes for approval
1,941,978,794  
Votes against 2,266,430,971  
Abstentions 33,453,959  
Broker non-votes 922,977,815  
 
7. The shareholder proposal regarding independent chair policy was not approved based upon the following votes:
     
Votes for approval
1,086,656,978  
Votes against 3,122,212,329  
Abstentions 32,981,454  
Broker non-votes 922,977,815  

 

(c) Not applicable.
(d) Based upon the results set forth in item (b) (4) above, and consistent with the Board's recommendation, the Board of Directors has determined that advisory votes on executive compensation will be submitted to shareholders on an annual basis until the next required vote on the frequency of such votes.    

 


SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

   
PFIZER INC.
     
Dated: May 1, 2017  
By:   /s/ Margaret M. Madden
         Margaret M. Madden
   
Title:  Senior Vice President & Corporate Secretary  
            Chief Governance Counsel